Skip to content
healthcare.dev
Get a free key

TEPEZZA

NDC 75987-130, teprotumumab, injection, powder, lyophilized, for solution, from Horizon Therapeutics USA, Inc..

Product NDC
75987-130
Status
Listed
Labeler
Horizon Therapeutics USA, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761143
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/75987-130 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TEPROTUMUMAB500 mg/1

Pharmacologic classes

Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]; Insulin-like Growth Factor-1 Receptor Inhibitors [MoA]

Package NDCNDC-11Package
75987-130-15759870130151 VIAL, SINGLE-DOSE in 1 CARTON (75987-130-15) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3e6c54a1-cefd-4a5b-a855-ab9f268b6cce

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=75987-130

Use it

Look up 75987-130 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/75987-130 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 75987-130. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.